Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ATAI |
---|---|---|
09:32 ET | 55547 | 1.855 |
09:34 ET | 17640 | 1.8523 |
09:36 ET | 71811 | 1.875 |
09:38 ET | 73046 | 1.825 |
09:39 ET | 14085 | 1.84 |
09:41 ET | 40426 | 1.84 |
09:43 ET | 19685 | 1.83 |
09:45 ET | 10758 | 1.825 |
09:48 ET | 6500 | 1.845 |
09:50 ET | 5205 | 1.8376 |
09:52 ET | 10000 | 1.83 |
09:54 ET | 141288 | 1.84 |
09:56 ET | 3140 | 1.845 |
09:57 ET | 3071 | 1.84 |
09:59 ET | 228 | 1.84 |
10:01 ET | 4804 | 1.82 |
10:03 ET | 5983 | 1.82 |
10:06 ET | 921 | 1.82 |
10:08 ET | 34821 | 1.8205 |
10:10 ET | 5541 | 1.8171 |
10:12 ET | 53556 | 1.8 |
10:14 ET | 18037 | 1.805 |
10:15 ET | 12920 | 1.8007 |
10:17 ET | 8244 | 1.8 |
10:19 ET | 8807 | 1.8 |
10:21 ET | 5932 | 1.8 |
10:24 ET | 13482 | 1.82 |
10:26 ET | 3334 | 1.82 |
10:28 ET | 1609 | 1.815 |
10:30 ET | 100928 | 1.86 |
10:32 ET | 72644 | 1.8399 |
10:33 ET | 974 | 1.8299 |
10:35 ET | 2002 | 1.825 |
10:37 ET | 12606 | 1.82 |
10:39 ET | 9938 | 1.83 |
10:42 ET | 3210 | 1.8271 |
10:44 ET | 6223 | 1.82 |
10:46 ET | 17729 | 1.825 |
10:48 ET | 2082 | 1.825 |
10:50 ET | 3956 | 1.815 |
10:51 ET | 6900 | 1.82 |
10:53 ET | 25837 | 1.82 |
10:55 ET | 5013 | 1.822 |
10:57 ET | 1433 | 1.82 |
11:00 ET | 7446 | 1.81 |
11:02 ET | 392 | 1.81 |
11:04 ET | 6885 | 1.81 |
11:06 ET | 2625 | 1.81 |
11:08 ET | 600 | 1.81 |
11:09 ET | 3912 | 1.818 |
11:11 ET | 6935 | 1.8101 |
11:13 ET | 2255 | 1.81 |
11:15 ET | 7278 | 1.825 |
11:18 ET | 400 | 1.825 |
11:20 ET | 1303 | 1.82 |
11:22 ET | 296 | 1.815 |
11:24 ET | 5030 | 1.81 |
11:26 ET | 7987 | 1.81 |
11:27 ET | 2300 | 1.81 |
11:29 ET | 1013 | 1.81 |
11:31 ET | 900 | 1.81 |
11:33 ET | 600 | 1.81 |
11:36 ET | 22443 | 1.8 |
11:38 ET | 1887 | 1.8 |
11:40 ET | 22142 | 1.8 |
11:42 ET | 33428 | 1.805 |
11:44 ET | 43001 | 1.79 |
11:45 ET | 2136 | 1.7914 |
11:47 ET | 1000 | 1.7953 |
11:49 ET | 18226 | 1.795 |
11:51 ET | 2550 | 1.799 |
11:54 ET | 1600 | 1.79 |
11:56 ET | 1300 | 1.79 |
11:58 ET | 15370 | 1.785 |
12:00 ET | 39736 | 1.77 |
12:02 ET | 12792 | 1.775 |
12:03 ET | 1790 | 1.775 |
12:05 ET | 17484 | 1.785 |
12:07 ET | 300 | 1.7822 |
12:09 ET | 6450 | 1.78 |
12:12 ET | 5944 | 1.775 |
12:14 ET | 1101 | 1.78 |
12:16 ET | 1310 | 1.77 |
12:18 ET | 3900 | 1.77 |
12:20 ET | 1400 | 1.775 |
12:21 ET | 9321 | 1.785 |
12:23 ET | 206 | 1.785 |
12:25 ET | 1300 | 1.785 |
12:27 ET | 153 | 1.7898 |
12:30 ET | 5618 | 1.785 |
12:32 ET | 450 | 1.78 |
12:34 ET | 8182 | 1.78 |
12:36 ET | 506 | 1.78 |
12:38 ET | 930 | 1.78 |
12:39 ET | 1866 | 1.788 |
12:41 ET | 4201 | 1.78 |
12:43 ET | 900 | 1.78 |
12:45 ET | 24542 | 1.77 |
12:48 ET | 6350 | 1.772 |
12:50 ET | 2200 | 1.77 |
12:52 ET | 4181 | 1.78 |
12:54 ET | 6654 | 1.7899 |
12:56 ET | 2870 | 1.785 |
12:57 ET | 1881 | 1.78 |
12:59 ET | 4511 | 1.79 |
01:01 ET | 1359 | 1.7862 |
01:03 ET | 2050 | 1.7876 |
01:06 ET | 1680 | 1.7897 |
01:08 ET | 2050 | 1.78 |
01:10 ET | 744 | 1.78 |
01:12 ET | 300 | 1.78 |
01:14 ET | 3610 | 1.7799 |
01:15 ET | 2113 | 1.7733 |
01:17 ET | 300 | 1.77 |
01:19 ET | 1312 | 1.77 |
01:21 ET | 300 | 1.776 |
01:24 ET | 629 | 1.77 |
01:26 ET | 685 | 1.77 |
01:28 ET | 63432 | 1.77 |
01:30 ET | 1100 | 1.77 |
01:32 ET | 200 | 1.77 |
01:33 ET | 51274 | 1.76 |
01:35 ET | 3055 | 1.755 |
01:37 ET | 29256 | 1.755 |
01:39 ET | 1100 | 1.7599 |
01:42 ET | 3200 | 1.7566 |
01:44 ET | 1495 | 1.75 |
01:46 ET | 1335 | 1.75 |
01:48 ET | 3869 | 1.7599 |
01:50 ET | 650 | 1.75 |
01:51 ET | 2239 | 1.75 |
01:53 ET | 2600 | 1.755 |
01:55 ET | 4410 | 1.7545 |
01:57 ET | 5981 | 1.7522 |
02:00 ET | 3040 | 1.75 |
02:02 ET | 214231 | 1.755 |
02:04 ET | 15703 | 1.765 |
02:06 ET | 164 | 1.765 |
02:08 ET | 9579 | 1.76 |
02:09 ET | 3715 | 1.76 |
02:11 ET | 7961 | 1.7599 |
02:13 ET | 20749 | 1.75 |
02:15 ET | 12085 | 1.75 |
02:18 ET | 4095 | 1.755 |
02:20 ET | 900 | 1.7599 |
02:22 ET | 700 | 1.75 |
02:24 ET | 2945 | 1.745 |
02:26 ET | 1400 | 1.74 |
02:27 ET | 2371 | 1.75 |
02:29 ET | 10264 | 1.7558 |
02:31 ET | 100 | 1.755 |
02:33 ET | 692 | 1.755 |
02:38 ET | 7697 | 1.75 |
02:40 ET | 1265 | 1.75 |
02:42 ET | 800 | 1.75 |
02:44 ET | 1414 | 1.75 |
02:45 ET | 3608 | 1.7425 |
02:47 ET | 2100 | 1.745 |
02:49 ET | 5845 | 1.745 |
02:51 ET | 7084 | 1.745 |
02:54 ET | 2852 | 1.745 |
02:56 ET | 13700 | 1.7536 |
02:58 ET | 1010 | 1.75 |
03:00 ET | 5906 | 1.75 |
03:02 ET | 100 | 1.745 |
03:03 ET | 287 | 1.745 |
03:05 ET | 1272 | 1.745 |
03:07 ET | 13657 | 1.745 |
03:09 ET | 759 | 1.745 |
03:12 ET | 900 | 1.745 |
03:14 ET | 3946 | 1.745 |
03:16 ET | 3889 | 1.745 |
03:18 ET | 690 | 1.74 |
03:20 ET | 2579 | 1.74 |
03:21 ET | 2235 | 1.74 |
03:23 ET | 9550 | 1.74 |
03:25 ET | 1725 | 1.748 |
03:27 ET | 27439 | 1.7499 |
03:30 ET | 9670 | 1.745 |
03:32 ET | 1100 | 1.745 |
03:34 ET | 365 | 1.745 |
03:36 ET | 3041 | 1.74 |
03:38 ET | 1100 | 1.74 |
03:39 ET | 4239 | 1.7446 |
03:41 ET | 2728 | 1.74 |
03:43 ET | 4800 | 1.74 |
03:45 ET | 175099 | 1.71 |
03:48 ET | 10234 | 1.7199 |
03:50 ET | 11208 | 1.71 |
03:52 ET | 4577 | 1.71 |
03:54 ET | 6990 | 1.71 |
03:56 ET | 8194 | 1.71 |
03:57 ET | 14861 | 1.71 |
03:59 ET | 31540 | 1.71 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ATAI Life Sciences NV | 283.9M | -7.1x | --- |
Inozyme Pharma Inc | 284.5M | -3.4x | --- |
Invivyd Inc | 286.1M | -1.3x | --- |
Opthea Ltd | 278.8M | -1.4x | --- |
Verastem Inc | 291.0M | -2.6x | --- |
Actinium Pharmaceuticals Inc | 291.9M | -5.7x | --- |
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $283.9M |
---|---|
Revenue (TTM) | $277.0K |
Shares Outstanding | 166.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.24 |
Book Value | $1.46 |
P/E Ratio | -7.1x |
Price/Sales (TTM) | 1,024.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -42,344.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.